We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Working group guidance.
An overview of the future requirements for rapid COVID-19 diagnostic assays for antigen lateral flow devices.
Data on the real-world efficacy of the COVID-19 vaccines.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Guidance and information about high consequence infectious diseases and their management in England.
Vaccine recommendations for adults and children during periods of vaccine supply constraints.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed.
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
Urgent safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).